Page 2 - Plasma Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics, and HI-Bio, a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BT

A first-of-its-kind study, spearheaded by an Indian-American scientist has concluded that those suffering from multiple myeloma, a blood cancer of plasma cells in the bone marrow, who also have diabetes have a reduced overall survival when compared to those without diabetes. In a subgroup analysis, this difference in survival due to diabetes was seen in white patients but not in Black patients, according to the study published medical journal Blood Advances. , Health News, Times Now

With treatment advances over the last few years, and particularly in recent months, multiple myeloma has become treatable and may soon be curable.

Rep. Steve Scalise, the number-two Republican in the House, announced he's been diagnosed with multiple myeloma.

Here are seven facts and myths about multiple myeloma, a common type of blood cancer arising from plasma cells that live inside the bone marrow